World Scientific
Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.

CLASSIFICATION OF PROGRESSIVE STAGES OF ALZHEIMER’S DISEASE IN MRI HIPPOCAMPAL REGION

    https://doi.org/10.4015/S1016237220500507Cited by:2 (Source: Crossref)

    Alzheimer’s disease (AD) is a type of neuronal brain disorder that is degenerative and results in memory loss, skills and cognitive changes. The primary diagnostic tests for the disorder are defined to be total brain atrophy and hippocampal atrophy. Early diagnosis is significant and the design of automatic systems is necessary for this disorder. A potential biomarker for AD is described using a hippocampal magnetic resonance imaging volumetry system that possesses certain limitations. This paper aims to analyze the transition of stages from normal cognition to different forms that ultimately leads to Alzheimer’s disease. The magnetic resonance imaging (MRI) images of different stages are derived from the standard database for the segregation of hippocampal region. Later, the morphological and radiomic features are extracted from the hippocampal regions of different stages, since the hippocampus plays a major role in memory. Classification of extracted features was performed using machine learning algorithms like ensemble tree classifiers. The classification results based on performance parameters specify that the bagged tree classifier is more efficient. The 4-way classification has an accuracy of 95.6% indicating certain misclassification between the two classes MCI and PMCI. To categorize these two classes, a 2-way classification is described that has an accuracy of 98.6%. With these results, an effective method is defined for the analysis and identification of the different progressive stages of Alzheimer’s disease.